SECAUCUS, N.J., Aug. 30, 2021 /PRNewswire/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the world's leading provider of
diagnostic information services, announced that it is scheduled to
speak at the Morgan Stanley 19th Annual Global
Healthcare Conference. Steve
Rusckowski, Chairman, CEO and President and Jim Davis, Executive Vice President, General
Diagnostics will discuss the company's vision, goals and two-point
strategy to accelerate growth and drive operational excellence, as
well as the company's current perspective on the impact of the
COVID-19 pandemic. The presentation is scheduled for Thursday, September 9, 2021, at 9:30 a.m. Eastern Time.
The presentation will be webcast live during the conference and
will be available on the company's investor relations page which
can be accessed at ir.QuestDiagnostics.com. In addition, the
archived webcast will be available within 24 hours after the
conclusion of the live event and will remain available until
October 9, 2021.
About Quest Diagnostics
Quest Diagnostics empowers
people to take action to improve health outcomes. Derived from the
world's largest database of clinical lab results, our diagnostic
insights reveal new avenues to identify and treat disease, inspire
healthy behaviors and improve health care management. Quest
Diagnostics annually serves one in three adult Americans and half
the physicians and hospitals in the
United States, and our nearly 50,000 employees understand
that, in the right hands and with the right context, our diagnostic
insights can inspire actions that transform lives.
www.QuestDiagnostics.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-morgan-stanley-19th-annual-global-healthcare-conference-301365248.html
SOURCE Quest Diagnostics